Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.China Medicine maintains rights to sell 2,300 drugs
The company won the exclusive rights through an on-line bidding system called the “Guangdong Sunshine Medicine Public Internet Bidding System’. Among the 2,300 products that the Company has
The company won the exclusive rights through an on-line bidding system called the “Guangdong Sunshine Medicine Public Internet Bidding System’. Among the 2,300 products that the Company has
The placement consists of 15.72 million units and four million prepaid warrant units. Each unit is comprised of one common share in the company and one share purchase
The Australian patent and divisional patent were recently sealed by IP Australia. A further two divisional applications have completed the examination process and have been accepted to grant.
In conjunction with this decision, the company also announced that it has terminated its supply agreement with Asubio Pharma and Nippon Soda for production of faropenem. These decisions
The company also announced that it was recently notified by its clinical research provider, BattelleCRO that Battelle Memorial Institute has decided to shut down BattelleCRO by June 30,
EpiCept intends to use the net proceeds it receives to meet its working capital needs and general corporate purposes through July 2008 and to pay certain fees owed
The notification was made in response to the company’s submission of a complete response to a prior notice from the FDA that had placed the drug on ‘clinical
In connection with this offering, Sequenom plans to grant to the underwriters a 30-day option to purchase up to an additional 825,000 shares of common stock. All of
Ta4 is a synthetic version of a biologically active, naturally occurring peptide that has been shown, in preclinical studies, to be effective in accelerating dermal, ophthalmic, and myocardial
The scientific collaboration is aimed at demonstrating the power and versatility of the Helicos true single molecule sequencing technology to measure the DNA sequence, methylation state, and mRNA